Regenerative Medicine · 2015 · 65 citations · 59 references
MedicineNeurobiologyNeuroscienceRegenerative MedicineStem Cell BiologyStem Cell TransplantationNeural RegenerationNeurodegenerative DiseasesNeurodegenerative DisordersNeurogenesisNeuroprotectionParkinson DiseaseAdipose Stem CellsAdipose-derived Mesenchymal Stem CellsDopaminergic NeuroprotectionHippocampal Memory FunctionNeural Stem Cell TransplantationParkinsonian NeuroprotectionParkinson’s Disease TreatmentSubventricular Zone Neurogenesis
BACKGROUND: Mesenchymal stem cells (MSC) are easily harvested, and possess anti-inflammatory and trophic properties. Furthermore, MSC promote neuroprotection and neurogenesis, which could greatly benefit neurodegenerative disorders, such as Parkinson's disease. METHODS: MSC were transplanted one week after 6-hydroxydopamine lesioning and effects were evaluated after 6 months. RESULTS: MSC localized around the substantia nigra and the arachnoid mater, expressing pericyte and endothelial markers. MSC protected dopamine levels and upregulated peripheral anti-inflammatory cytokines. Furthermore, adipose-derived MSC increased neurogenesis in hippocampal and subventricular regions, and boosted memory functioning. CONCLUSION: Considering that hyposmia and loss of memory function are two major nonmotor symptoms in Parkinson's disease, transplants with modulatory effects on the hippocampus and subventricular zone could provide a disease-modifying therapy.
59
Staging of brain pathology related to sporadic Parkinson’s disease
Heiko Braak, Kelly Del Tredici, Udo Rüb et al. · Neurobiology of Aging · 2002 · 10.8K citations
Medicine, Neurology, Neuroscience +13
Prevalence and Characteristics of Dementia in Parkinson Disease
Dag Aarsland, Kjeld Andersen, Jan Larsen et al. · Archives of Neurology · 2003 · 1.4K citations